Fig. 1

Experimental Roadmap and Inclusion/Exclusion Criteria. (A) Retrospective analysis of clinical applicability and efficacy of GOI-RADS; (B) Development of a new grading system based on CEUS and RTE findings; (C) Simplified the established newly grading system; (D) Prospective validation of the clinical value of the new grading system